Stop if you don’t have an unambiguous drug effect for your new molecular entity! ブログ Stop if you don’t have an unambiguous drug effect for your new molecular entity! As a pharmacologist, I’ve always been curious about how drugs work. A favorite time-killer while…Certara2023年8月18日
Computational neurosciences and quantitative systems pharmacology: a powerful combination for supporting drug development in neurodegenerative diseases Publication Computational neurosciences and quantitative systems pharmacology: a powerful combination for supporting drug development in neurodegenerative diseases Successful clinical development of new therapeutic interventions is notoriously difficult, especially in neurodegenerative diseases, where…Certara2023年8月15日
IRA impacts: First 10 drugs selected for the Drug Price Negotiation Program On-Demand Webinar IRA impacts: First 10 drugs selected for the Drug Price Negotiation Program The Inflation Reduction Act (enacted in August 2022) contains profound changes for the healthcare and…Certara2023年8月15日
Secondary Intelligence™: Empowering Decision-Making in Drug Development & Safety Assessment Blog Secondary Intelligence™: 医薬品開発と安全性評価の意思決定を加速・強化 Adverse effects of drugs pose potential harm to patients and can hinder or halt the…Certara2023年8月11日
Model-Informed Formulation Development: Insights from a Case Study Blog モデルを活かした製剤開発:事例から得られたインサイト In a captivating webinar led by industry experts, Dr. Swati Jaiswal, Senior PBPK Consultant at…Certara2023年8月10日
Certara collaborates with Korea Institute of Toxicology to ensure FDA submission-ready SEND dataset Announcement Korea Institute of Toxicology 、FDA申請可能なSENDデータセット作成のためサターラと協力 グローバルガイドラインに沿って前臨床試験データ管理を最適化するのに役立つソフトウェアの導入Seoul,…Certara2023年8月3日
Drug Manufacturers’ Recent Drop in Insulin Prices in the United States Blog Drug Manufacturers’ Recent Drop in Insulin Prices in the United States The prevalence of diabetes in the US is incredibly high and affects more than 10%…Certara2023年8月3日
How value communication can make or break your commercial success? オンデマンド・ウェビナー How value communication can make or break your commercial success? Are you struggling to effectively communicate the value of your products or services in today's…Certara2023年8月2日
Certara and Drugs for Neglected Diseases initiative (DNDi) Partnering to Fast-track Data Submissions and Accelerate Drug Approvals for Neglected Patients Announcement Certara and Drugs for Neglected Diseases initiative (DNDi) Partnering to Fast-track Data Submissions and Accelerate Drug Approvals for Neglected Patients DNDi Utilizing Pinnacle 21 Enterprise (P21E), Certara’s Data Science platform for Biostatistics, Data Management, and…Certara2023年7月31日